This activity will focus on updates on influenza vaccination and treatment for pediatric patients. Influenza vaccine doses have changed for some manufacturers, and there is new data on the use of baloxavir in children. Discussion on early research on using oseltamivir and baloxavir combination therapy will also occur.
Activity Fee: Member - Free / Non-Member - Not Available
Registration for this webinar will be approved for ASHP Members Only. ASHP member ID number is required to register. Find your ASHP membership ID here. Not an ASHP member?
- List appropriate influenza vaccine doses for children 6 months and older.
- Describe the outcomes of the clinical trial of baloxavir in children.
- Discuss appropriate treatment for a child diagnosed with influenza based on current evidence.
- Rachel Meyers, Pharm.D., Clinical Associate Professor, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, NJ
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based activity will provide 1.0 hour (0.1 CEUs) of continuing pharmacy education credits (ACPE#: 0204-0000-20-002-L01-P).
Continuing pharmacy education (CPE) for this activity will be processed on ASHP's eLearning portal and reported directly to CPE Monitor. After completion of the live webinar, you will process and claim CPE credit online at elearning.ashp.org. Pharmacists will need the enrollment code that will be announced at the end of the webinar and your eProfile ID from NABP to earn CPE credits. Follow the prompts to claim credit within 60 days after completing the activity.
CE Activity Announcement
The ASHP Section of Clinical Specialists and Scientists is recognized for the organization of this webinar continuing education activity.
For questions and comments, please email email@example.com.